|
1
|
Daniel C, Bell C, Burton C, Harguindey S,
Reshkin SJ and Rauch C: The role of proton dynamics in the
development and maintenance of multidrug resistance in cancer.
Biochim Biophys Acta. 1832:606–617. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang F, Wu XN, Chen J, Wang WX and Lu ZF:
Resveratrol reverses multidrug resistance in human breast cancer
doxorubicin-resistant cells. Exp Ther Med. 7:1611–1616.
2014.PubMed/NCBI
|
|
3
|
Molinas A, Sicard G and Jakob I:
Functional evidence of multidrug resistance transporters (MDR) in
rodent olfactory epithelium. PLoS One. 7:e361672012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu F, Shao ZY, Zhai BJ, Zhao CL and Shen
DM: Ultrasound reverses multidrug resistance in human cancer cells
by altering gene expression of ABC transporter proteins and Bax
protein. Ultrasound Med Biol. 37:151–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dean M, Hamon Y and Chimini G: The human
ATP-binding cassette (ABC) transporter superfamily. J Lipid Res.
42:1007–1017. 2001.PubMed/NCBI
|
|
6
|
Wan X and Sun G: The research progress of
immune mechanism of reverse tumor multi-drug resistance. An Hui Yi
Yao. 10:401–402. 2006.(In Chinese).
|
|
7
|
Gomes-Giacoia E, Miyake M, Goodison S,
Sriharan A, Zhang G, You L, Egan JO, Rhode PR, Parker AS, Chai KX,
et al: Intravesical ALT-803 and BCG treatment reduces tumor burden
in a carcinogen induced bladder cancer rat model; a role for
cytokine production and NK cell expansion. PLoS One. 9:e967052014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnson SD, De Costa AM and Young MR:
Effect of the premalignant and tumor microenvironment on immune
cell cytokine production in head and neck cancer. Cancers (Basel).
6:756–770. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhen JH: Progress in research on
interleukin −2. Strait Pharmaceutical Journal. 18:1–3. 2006.
|
|
10
|
Liu YL, Chen TG and Liu XL: Research
progress of interferon. Progress in Veterinary Medicine. 29:81–84.
2008.
|
|
11
|
Fu S and Qian YK: Research progress of
tumor necrosis factor. International Journal of Immunology.
5:252–257. 1993.
|
|
12
|
Tu WQ and Yang XQ: Regulation of cytokine
immune response and its clinical significance. Foreign Medical
Sciences(Section of Pediatrics). 5:228–232. 1993.
|
|
13
|
Cun YM, Yang YX, Xiang Y, et al: IL-2 gene
transfection reversing multidrug resistance in choriocarcinoma cell
line. Basic and Clinical Medicine. 21:523–526. 2001.
|
|
14
|
Hu JW, Shen ZY, Yang JC, et al:
Combination of interferon gamma and Vera Pammy to reverse multidrug
resistance in human lung cancer cell line. Suzhou University
Journal of Medical Science. 23:16–18. 2003.
|
|
15
|
Malorni W, Rainaldi G, Tritarelli E, et
al: Tumor necrosis factor alpha is a powerful apoptotic inducer in
lymphoid leukemic cells expressing the P-170 glycoprotein.
International Journal of Cancer. 67:238–47. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Fu L and Liu Z: Reversal of
multidrug resistance in cancer cell by verapamil: A research
progress. Foreign Medical Science (Section of Pharmacy).
34:190–193. 2007.(In Chinese).
|
|
17
|
Jiao B: Experimental study of reversal of
multidrug resistance by cyclosporin a in various human gliom cell
lines. Zhong Liu Fang Zhi Yan Jiu. 28:457–459. 2001.(In
Chinese).
|
|
18
|
Xu AH, Chen HS and Zhuo C: The inhibitory
effect of Ginkgo biloba endocarp polysaccharides (GBEP) on human
cancer cell strains and its synergic effect in combination with
adriamycin. Zhong Guo Xin Yao Za Zhi. 9:753–755. 2000.(In
Chinese).
|
|
19
|
Chen Y, Mao LL, Hu BY, Chen HS and Xu AH:
Synergistic attenuated antitumor effect of Ginkgo biloba exocarp
extracts combined with cis-dichlorodiamineplatinum in S180
tumor-bearing mice. Zhong Guo Xin Yao Za Zhi. 23:1569–1573.
2014.(In Chinese).
|
|
20
|
Xu AH, Ren L, Zheng YY and Chen HS:
Immunomodulatory effect of Ginkgo biloba exocarp polysaccharides on
immunosuppressive mice induced by cyclophosphamide. Zhong Guo Yao
Li Xue Yu Du Li Xue Za Zhi. 22:69–72. 2008.(In Chinese).
|
|
21
|
Chen HS, Zhuo F and Chu YF: Clinical study
on treatment of patients with upper digestive tract malignant
tumors of middle and late stage with Ginkgo biloba exocarp
polysaccharides capsule preparation. Zhong Xi Yi Jie He Xue Bao.
1:189–191. 2003.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhai F and Chen HS: Ginkgo biloba exocarp
Polysaccharide preparation in the treatment of 84 cases of advanced
cancer. Liao Ning Zhong Yi Za Zhi. 29:5642002.
|
|
23
|
Shen TT, Xu AH, Zheng YY, et al:
Anti-metastasis effect of Ginkgo biloba exocarp extracts on
metastasis of Lewis lung cancer in C57BL /6J mice and its
mechanism. Chin J of Pharmacol Toxicol. 27:67–71. 2013.
|
|
24
|
Xu JL, Wang ZH and FJ S: Establishment of
tumor multi-drug resistance mice model induced by combination
chemotherapeutic in vivo. Shi Yan Dong Wu Yu Bi Jiao Yi Xue.
25:215–217. 2005.
|
|
25
|
Chen Q, Li GH and Sun FJ: Establishment of
obtained multidrug resistance model of S180 cell line mice used for
study on Chinese materia medica and its stability. Zhong Cao Yao.
37:1691–1694. 2006.(In Chinese).
|
|
26
|
Wu Q, Xu A, Yang Q, Wang LX and Chen HS:
Influence of effective part GBEE-2 of exocarpium ginkgo extracts on
apoptosis and apoptotic pathway of human gastric adenocarcinoma
cell line SGC-7901. Traditional Chinese Drug Research and Clinical
Pharmacology. 22:270–273. 2011.
|
|
27
|
Cao CJ: Inhibitory effect of extract of
Ginkgo biloba extract on liver cancer in mice and its effect on
survivin expression. Shi Zhen Guo Yi Guo Yao. 26:1322–1324.
2015.
|
|
28
|
Zrieki A, Farinotti R and Buyse M:
Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic
acid-induced P-glycoprotein up-regulation in vitro and in vivo. Eur
J Pharmacol. 636:189–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Loetchutinat C, Saengkhae C, Marbeuf-Gueye
C and Garnier-Suillerot A: New insights into the
P-glycoprotein-mediated effluxes of rhodamines. Eur J Biochem.
270:476–485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu SY, Bian RL and Chen X: Screening
method of animal tumor in vivoExperimental Methodology of
Pharmacology. 3rd. People's Medical Publishing House; Beijing: pp.
1757–1784. 2002
|
|
31
|
Isabel D, Ferreira I, Virgílio E, do
Rosário I and Pedro VL: Cravo* 2: Real-time quantitative PCR with
SYBR Green I detection forestimating copy numbers of nine drug
resistance candidate genes in Plasmodium falciparum. Malaria
Journal. 5:1–6. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y, Jia YJ and Li XJ: Resistance
reversal effect of astragalus polysaccharides for injection on
cisplatin-resistant human lung adenocarcinoma cell line A549/DDP.
Drug Evaluation Research. 35:417–419. 2012.(In Chinese).
|
|
33
|
Wu HY, Chen YM, Lin L, Qiu QA and Liu N:
Lentinan enhances cisplatin-mediated inhibition of cell
proliferation in human gastric cancer cell line SGC-7901. Shi Jie
Hua Ren Xiao Hua Za Zhi. 19:344–348. 2011.(In Chinese).
|
|
34
|
Li ZH, An C, Hu KW, Zhou KH, Duan HH and
Tang MK: Multidrug resistance reversal activity of total alkaloid
from Fritillaria thunbergii on cisplatin-resistant hum an lung
adenocarcinom a A549/DDP cells. Zhong Guo Yao Li Xue Yu Du Li Xue
Za Zhi. 27:315–320. 2013.(In Chinese).
|
|
35
|
Zhu C, Liu XF and Li G: Effect of Brucea
Javanica oil emulsion combined with adramycin for refractory
malignant pleural effusion. Shi Yong Quan Ke Yi Xue. 5:871–873.
2007.(In Chinese).
|
|
36
|
Hennessy M and Spiers JP: A primer on the
mechanics of P-glycoprotein the multidrug transporter. Pharmacol
Res. 55:1–15. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kruh GD and Belinsky MG: The MRP family of
drug efflux pumps. Oncogene. 22:7537–7552. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peng YM, Wang N, Wang YF, Han L, Zhang Y,
Jiang JH, Zhou YB and Wang QD: Correlation between reversing effect
of cepharanthine hydrochloride on multidrug resistance and
P-glycoprotein expression and function of K562/ADR cells. Yao Xue
Xue Bao. 47:594–599. 2012.(In Chinese). PubMed/NCBI
|
|
39
|
Niethammer AG, Wodrich H, Loeffler M, Lode
HN, Emmerich K, Abdollahi A, Krempien R, Debus J, Huber PE and
Reisfeld RA: Multidrug resistance-1 (MDR-1): A new target for T
cell-based immunotherapy. FASEB J. 19:158–159. 2005.PubMed/NCBI
|
|
40
|
Shi YJ, Ren HY, Cen XN, Zhu Q and Yu JR:
Immunological effector cells enhance apoptosis induced by
adriamycin in a multi-drug resistant human breast cancer cell line.
Zhonghua Zhong Liu Za Zhi. 28:188–191. 2006.(In Chinese).
PubMed/NCBI
|
|
41
|
Wang L, Deng Q, Wang J, Bai X, Xiao X, Lv
HR, Zhao MF and Liu PJ: Effect of CIK on multidrug-resistance
reversal and increasing the sensitivity of ADR in K562/ADR cells.
Oncol Lett. 8:1778–1782. 2014.PubMed/NCBI
|
|
42
|
Ping CQ, Zhang YJ, Sun GX, Dong M, Zhou
XL, Ping J, Liu Y Qm and Hong LJ: The expression effect of DC-CIK
on K562/A multidrug resistance gene mdr1. Xian Dai Sheng Wu Yi Xue
Jin Zhan. 14:2667–2671. 2014.(In Chinese).
|
|
43
|
Wang CH, Pan CX and Wang W: The reversal
study of alpha-interferon on human breast cancer multidrug
resistance cell lines MX-1/Taxo (MX-1/T). Dang Dai Yi Xue.
20:17–19. 2014.(In Chinese).
|
|
44
|
Li Y, Zou Y, Cai B, Yang B, Ying B, Shi Y
and Wang L: The associations of IL-18 serum levels and promoter
polymorphism with tacrolimus pharmacokinetics and hepatic allograft
dysfunction in Chinese liver transplantation recipients. Gene.
491:251–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu CF, Hong JH and Chiang CS: The roles of
macrophages and nitric oxide in interleukin-3-enhanced
HSV-Sr39tk-mediated prodrug therapy. PLoS One. 8:e565082013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li J, Fu EC, Xu AH, et al: Effect of GBEE
on the levels of IL-2, IL-12, TNF- and TGF- in tumor bearing mice.
Chinese Journal of Immunology. 28:415–417. 2012.
|
